Despite COVID-19, pharma R&D funding at all-time high: IQVIA
Despite COVID-19, pharma R&D funding at all-time high: IQVIA According to the clinical research solutions firm, disruptions due to the pandemic did not stop the industry from fueling R&D at unprecedented levels. The IQVIA Institute for Human Data Science has released its latest industry latest report, Global Trends in R&D: Overview Through 2020. According to the findings, research and development funding maintained historically high levels, thanks to new funding sources, strategic transactions, and other activity. Murray Aitken, executive director of the IQVIA Inst...
Source: outsourcing-pharma.com